ArticleNature2022
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2.
Abstract readPublished Erratum
In one paragraph
Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- SARS-CoV-2 keeps evolving, so must our research efforts.National science review · 2025Article
- SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 or XBB.1.5.Cell reports. Medicine · 2024Article
- Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets.Nature communications · 2023Article
Corrections and comments
- Erratum for
Authors and funding
43 authors.
Lucy G Thorne *Division of Infection and Immunity, University College London, London, UK.ORCID http://orcid.org/0000-0001-7358-6047
Mehdi Bouhaddou *QBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
Ann-Kathrin Reuschl *Division of Infection and Immunity, University College London, London, UK.
Lorena Zuliani-Alvarez *QBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
Ben PolaccoQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-1570-9234
Adrian PelinQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
Jyoti BatraQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
Matthew V X WhelanDivision of Infection and Immunity, University College London, London, UK.
Myra HosmilloDivision of Virology, Department of Pathology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Andrea FossatiQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-5170-4903
Roberta RagazziniEpithelial Stem Cell Biology and Regenerative Medicine Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-2186-293X
Irwin JungreisMIT Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-3197-5367
Manisha UmmadiQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
Ajda RojcQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
Jane TurnerDivision of Infection and Immunity, University College London, London, UK.
Marie L BischofDivision of Infection and Immunity, University College London, London, UK.
Kirsten ObernierQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-4025-1299
Hannes BrabergQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-7070-2257
Margaret SoucherayQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
Alicia RichardsQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
Kuei-Ho ChenQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-6541-0578
Bhavya HarjaiQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
Danish MemonEuropean Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-1365-0710
Joseph HiattQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
Romel RosalesDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Briana L McGovernDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-0492-9904
Aminu JahunDivision of Virology, Department of Pathology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-4585-1701
Jacqueline M FabiusQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
Kris WhiteDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0003-0889-0506
Ian G GoodfellowDivision of Virology, Department of Pathology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-9483-510X
Yasu TakeuchiDivision of Infection and Immunity, University College London, London, UK.
Paola BonfantiEpithelial Stem Cell Biology and Regenerative Medicine Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0001-9655-3766
Kevan ShokatQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-8590-7741
Natalia JuraQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-5129-641X
Klim VerbaQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-2238-8590
Mahdad NoursadeghiDivision of Infection and Immunity, University College London, London, UK.ORCID http://orcid.org/0000-0002-4774-0853
Pedro BeltraoQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
Manolis KellisMIT Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-7113-9630
Danielle L SwaneyQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-6119-6084
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-6551-1827
Clare JollyDivision of Infection and Immunity, University College London, London, UK. c.jolly@ucl.ac.uk.ORCID http://orcid.org/0000-0002-4603-2281
Greg J TowersDivision of Infection and Immunity, University College London, London, UK. g.towers@ucl.ac.uk.ORCID http://orcid.org/0000-0002-7707-0264
Nevan J KroganQBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA. nevan.krogan@ucsf.edu.ORCID http://orcid.org/0000-0003-4902-337X
Funding
Medical Scientist Training Program (T32 NRSA Training Grant)T32GM141323 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Aimee Kao · 2021 to 2026
$10.5MMedical Research Council G0801172Medical Research Council MR/S023380/1NIGMS NIH HHS T32 GM141323
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.